Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
18.5
% (year-on-year increase in consolidated revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Earnings presentation materialsSecond quarter of the fiscal year ending March 202712 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥26,893 million+18.5%
Operating profit¥3,990 million+46.4%
Ordinary income¥4,577 million+41.7%
Net income¥3,392 million +47.5%interim net income attributable to owners of the parent
Gross Profit Margin42.6 %
Operating profit margin14.8 %
Selling, general and administrative expenses
SG&A-to-sales ratioSlight decrease year on year (slight increase on a quarterly basis)
Results for the three months of the current quarterRevenue: ¥13,948 million; operating profit: ¥2,611 million; ordinary profit: ¥2,341 million (as shown in the quarterly graph)
Full-year earnings forecast
Net Sales
¥54,175 million
Gross profit
¥22,800 million
Operating profit
¥7,537 million
Ordinary income
¥8,655 million
Profit attributable to owners of the parent
¥6,437 million
Earnings per share
289.57 yen
ROE
14.7 %
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Effect of higher revenue, lower cost of sales ratio, higher SG&A expenses, and increased equity-method investment gains. The bridge by individual factor is not disclosed.
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate
Dollar157 Yen, period average
Euro181 Yen, period average
Chinese yuan23.3 Yen, period average
Market EnvironmentAssumes strong growth in the semiconductor and LCD, surface treatment equipment, and medical equipment markets.
New initiatives
Payment of an ¥10 commemorative dividend marking the 10th anniversary of the listing; construction of a new building at the Miharu PlantKey KPIsA metric the company considers important as a management benchmark.
- Year-on-year revenue growth in the domestic medical equipment market46.5 %
- Year-on-year revenue growth in the U.S. water treatment market11.4 %
- Year-on-year revenue growth in the Chinese semiconductor and LCD markets29.8 %
- Overseas Revenue Ratio54 %
- ROE14.7 %
Segment results
Not disclosed (sales by market and product are provided)Medium-term management plan targets
The company expects to broadly achieve the financial targets of Medium-Term Management Plan 2027 one year ahead of schedule. Details of the target figures are not disclosed.Financial targets
ROE
Forecast value14.7 %
Number of stores and locations
Production and sales locations are described, but the number of locations opened and closed during the period is not disclosed.Number of employees
Number of Employees1,146 consolidated; 790 non-consolidated (as of 31 March 2026)
Capital expenditures
¥3,092 million cumulative second quarter of the fiscal year ending March 2027
Annual Dividend
Annual dividend per share102 yen
Interim and Year-End BreakdownAn ¥10 commemorative dividend marking the 10th anniversary of the listing will be paid as the interim dividend. Other details are not disclosed.
Payout ratio
Rate38.7 %
PolicyPayout ratio of at least 35%; minimum dividend of ¥70
| Item | Details |
|---|---|
| Document type | Earnings presentation materials |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥26,893 million (YoY +18.5%) |
| Operating profit | ¥3,990 million (YoY +46.4%) |
| Ordinary income | ¥4,577 million (YoY +41.7%) |
| Net income | ¥3,392 million (interim net income attributable to owners of the parent) (YoY +47.5%) |
| Gross Profit Margin | 42.6 % |
| Operating profit margin | 14.8 % |
| Selling, general and administrative expenses | value Not disclosed / SG&A-to-sales ratio Slight decrease year on year (slight increase on a quarterly basis) |
| Results for the three months of the current quarter | Revenue: ¥13,948 million; operating profit: ¥2,611 million; ordinary profit: ¥2,341 million (as shown in the quarterly graph) |
| Full-year earnings forecast | Net Sales ¥54,175 million / Gross profit ¥22,800 million / Operating profit ¥7,537 million / Ordinary income ¥8,655 million / Profit attributable to owners of the parent ¥6,437 million / Earnings per share 289.57 yen / ROE 14.7 % |
| Segment results | Not disclosed (sales by market and product are provided) |
| Breakdown of Factors Affecting the Change | Effect of higher revenue, lower cost of sales ratio, higher SG&A expenses, and increased equity-method investment gains. The bridge by individual factor is not disclosed. |
| Key KPIs | Indicator name Year-on-year revenue growth in the domestic medical equipment market / Value 46.5 %, Indicator name Year-on-year revenue growth in the U.S. water treatment market / Value 11.4 %, Indicator name Year-on-year revenue growth in the Chinese semiconductor and LCD markets / Value 29.8 %, Indicator name Overseas Revenue Ratio / Value 54 %, Indicator name ROE / Value 14.7 % |
| Number of stores and locations | Production and sales locations are described, but the number of locations opened and closed during the period is not disclosed. |
| Number of employees | Number of Employees 1,146 consolidated; 790 non-consolidated (as of 31 March 2026) / Changes during the period and hiring plan Not disclosed |
| Assumptions Underlying the Business Outlook | Exchange rate Dollar 157 Yen, period average / Euro 181 Yen, period average / Chinese yuan 23.3 Yen, period average / Market Environment Assumes strong growth in the semiconductor and LCD, surface treatment equipment, and medical equipment markets. |
| Medium-term management plan targets | The company expects to broadly achieve the financial targets of Medium-Term Management Plan 2027 one year ahead of schedule. Details of the target figures are not disclosed. |
| Financial targets | ROE Forecast value 14.7 % |
| Annual Dividend | Annual dividend per share 102 yen / Interim and Year-End Breakdown An ¥10 commemorative dividend marking the 10th anniversary of the listing will be paid as the interim dividend. Other details are not disclosed. |
| Payout ratio | Rate 38.7 % / Policy Payout ratio of at least 35%; minimum dividend of ¥70 |
| Capital expenditures | ¥3,092 million (cumulative second quarter of the fiscal year ending March 2027) |
| New initiatives | Payment of an ¥10 commemorative dividend marking the 10th anniversary of the listing; construction of a new building at the Miharu Plant |
Items this document does not state (8)
Progress against full-year forecastSelf-assessment against the planUnit price and quantity metricsRisk amount incorporated into the outlookAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to strong performance in the domestic medical equipment market, the U.S. water treatment market, and the semiconductor and LCD markets in China, South Korea and Taiwan, revenue benefited from the foreign-exchange translation impact of the yen's depreciation. The cost of sales ratio declined as inventory was optimized in line with revenue growth, and operating profit increased due to the effect of higher revenue and other factors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.